Victory Capital Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $148K | Sell |
15,944
-206
| -1% | -$1.91K | ﹤0.01% | 2287 |
|
|
2025
Q1 | $118K | Sell |
16,150
-52,721
| -77% | -$386K | ﹤0.01% | 2294 |
|
|
2024
Q4 | $588K | Buy |
68,871
+51,671
| +300% | +$441K | ﹤0.01% | 1989 |
|
|
2024
Q3 | $150K | Sell |
17,200
-203
| -1% | -$1.77K | ﹤0.01% | 2272 |
|
|
2024
Q2 | $119K | Buy |
17,403
+4,695
| +37% | +$32.1K | ﹤0.01% | 2273 |
|
|
2024
Q1 | $116K | Buy |
12,708
+2,573
| +25% | +$23.4K | ﹤0.01% | 2286 |
|
|
2023
Q4 | $45.2K | Buy |
+10,135
| New | +$45.2K | ﹤0.01% | 2449 |
|
|
2022
Q3 | – | Sell |
-10,137
| Closed | -$41K | – | 2750 |
|
|
2022
Q2 | $41K | Sell |
10,137
-50
| -0.5% | -$202 | ﹤0.01% | 2571 |
|
|
2022
Q1 | $36K | Sell |
10,187
-289
| -3% | -$1.02K | ﹤0.01% | 2617 |
|
|
2021
Q4 | $73K | Sell |
10,476
-323
| -3% | -$2.25K | ﹤0.01% | 2618 |
|
|
2021
Q3 | $108K | Sell |
10,799
-381
| -3% | -$3.81K | ﹤0.01% | 2606 |
|
|
2021
Q2 | $159K | Sell |
11,180
-1,537,447
| -99% | -$21.9M | ﹤0.01% | 2555 |
|
|
2021
Q1 | $25.4M | Buy |
1,548,627
+461,855
| +42% | +$7.58M | 0.03% | 815 |
|
|
2020
Q4 | $22.5M | Buy |
+1,086,772
| New | +$22.5M | 0.03% | 836 |
|
|
2020
Q2 | – | Sell |
-14,658
| Closed | -$72K | – | 3019 |
|
|
2020
Q1 | $72K | Buy |
+14,658
| New | +$72K | ﹤0.01% | 2635 |
|
|
2019
Q4 | – | Sell |
-7,115
| Closed | -$22K | – | 3053 |
|
|
2019
Q3 | $22K | Buy |
+7,115
| New | +$22K | ﹤0.01% | 3014 |
|